Susan Quaggin

Director/Board Member en ABBVIE INC. .

Fortuna: 240 736 $ al 31/03/2024

Health Technology

Health Services

Perfil

Susan E.
Quaggin currently works at AbbVie, Inc., as Independent Director from 2023, American Society of Nephrology, as Director, and Mannin Research, Inc., as Director & Chief Scientific Officer.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
ABBVIE, INC. 0.00%	03/05/2024	1 322 ( 0.00% )	240 736 $	31/03/2024

Cargos activos de Susan Quaggin

Empresas	Cargo	Inicio
ABBVIE INC.	Director/Board Member	11/10/2023
Mannin Research, Inc. Mannin Research, Inc. BiotechnologyHealth Technology Mannin Research, Inc. develops novel therapeutics for vascular diseases. It also operates a research platform that develops a class of drugs to treat diseases such as glaucoma and cystic kidney disease. The company is headquartered in Toronto, Canada.	Chief Tech/Sci/R&D Officer	-
American Society of Nephrology American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC.	Director/Board Member	-

Todos los cargos activos de Susan Quaggin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Susan Quaggin.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ABBVIE INC.	Health Technology

Empresas privadas	2
American Society of Nephrology American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC.	Health Services
Mannin Research, Inc. Mannin Research, Inc. BiotechnologyHealth Technology Mannin Research, Inc. develops novel therapeutics for vascular diseases. It also operates a research platform that develops a class of drugs to treat diseases such as glaucoma and cystic kidney disease. The company is headquartered in Toronto, Canada.	Health Technology

Ver las conexiones de la empresa